Lineage Cell Therapeutics, Inc. (LCTX)
1.09
+0.01
(+0.93%)
USD |
NYAM |
Sep 08, 16:00
1.10
+0.01
(+0.92%)
After-Hours: 07:30
Lineage Cell Therapeutics Price : 1.09 for Sept. 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 1.10 | 1.16 | 1.09 | 1.09 | 1.312M |
| Sep 04, 2026 | 1.09 | 1.105 | 1.08 | 1.08 | 535726.0 |
| Sep 03, 2026 | 1.11 | 1.12 | 1.085 | 1.10 | 917013.0 |
| Sep 02, 2026 | 1.08 | 1.135 | 1.08 | 1.11 | 675975.0 |
| Sep 01, 2026 | 1.10 | 1.12 | 1.08 | 1.08 | 905661.0 |
| Aug 31, 2026 | 1.11 | 1.128 | 1.10 | 1.10 | 583453.0 |
| Aug 28, 2026 | 1.16 | 1.176 | 1.11 | 1.11 | 587284.0 |
| Aug 27, 2026 | 1.11 | 1.185 | 1.102 | 1.16 | 970055.0 |
| Aug 26, 2026 | 1.16 | 1.16 | 1.095 | 1.12 | 807687.0 |
| Aug 25, 2026 | 1.08 | 1.13 | 1.08 | 1.13 | 1.032M |
| Aug 24, 2026 | 1.08 | 1.11 | 1.06 | 1.09 | 607681.0 |
| Aug 21, 2026 | 1.09 | 1.108 | 1.07 | 1.08 | 716424.0 |
| Aug 20, 2026 | 1.09 | 1.099 | 1.04 | 1.08 | 1.474M |
| Aug 19, 2026 | 1.09 | 1.13 | 1.079 | 1.10 | 951490.0 |
| Aug 18, 2026 | 1.06 | 1.08 | 1.045 | 1.06 | 1.112M |
| Aug 17, 2026 | 1.07 | 1.107 | 1.06 | 1.06 | 795388.0 |
| Aug 14, 2026 | 1.06 | 1.09 | 1.05 | 1.07 | 1.129M |
| Aug 13, 2026 | 1.11 | 1.118 | 1.05 | 1.06 | 957589.0 |
| Aug 12, 2026 | 1.12 | 1.129 | 1.09 | 1.10 | 698007.0 |
| Aug 11, 2026 | 1.13 | 1.148 | 1.095 | 1.12 | 763808.0 |
| Aug 10, 2026 | 1.10 | 1.15 | 1.09 | 1.13 | 752414.0 |
| Aug 07, 2026 | 1.10 | 1.14 | 1.08 | 1.10 | 833645.0 |
| Aug 06, 2026 | 1.16 | 1.18 | 1.12 | 1.13 | 711637.0 |
| Aug 05, 2026 | 1.12 | 1.15 | 1.10 | 1.14 | 693086.0 |
| Aug 04, 2026 | 1.13 | 1.15 | 1.11 | 1.12 | 860805.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.43 |
| Amgen, Inc. | 393.17 |
| Anika Therapeutics, Inc. | 21.04 |
| BioCryst Pharmaceuticals, Inc. | 9.065 |
| Imunon, Inc. | 1.54 |
Price Related Metrics
| PS Ratio | 20.72 |
| PEG Ratio | -6.353 |
| Price to Book Value | 4.526 |
| Earnings Yield | -16.91% |
| Market Cap | 275.67M |
| PEGY Ratio | -6.353 |